Toxoplasma gondii infection and schizophrenia: A case control study in a low Toxoplasma seroprevalence Mexican population

Parasitology International

Volumn 60, Issue 2, 2011, Pages 151-155

  Alvarado Esquivel, Cosme ^a   Urbina Álvarez, Jesús David ^b   Estrada Martínez, Sergio ^a   Torres Castorena, Alejandro ^b   Molotla de León, Gabriel ^c   Liesenfeld, Oliver ^d   Dubey, Jitender P ^e  

^a UNIVERSIDAD JUÁREZ DEL ESTADO DE DURANGO   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c Hospital of Mental Health Dr Miguel Vallebueno   (Mexico)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

Case control study; Epidemiology; Schizophrenia; Seroprevalence; Toxoplasma gondii

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AGED; ANTIBODY PRODUCTION; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; MEXICO; PRIORITY JOURNAL; SCHIZOPHRENIA; SEROPREVALENCE; TOXOPLASMA GONDII; TOXOPLASMOSIS;

TOXOPLASMA; TOXOPLASMA GONDII;

EID: 79953767534     PISSN: 13835769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parint.2010.12.003     Document Type: Article

References (32)

1. Hill D.E., Chirukandoth S., Dubey J.P. Biology and epidemiology of Toxoplasma gondii in man and animals. Anim Health Res Rev 2005, 6:41-61.
2. Dubey J.P. Toxoplasmosis of animals and humans 2009, CRC Press, Boca Raton, Florida. 2nd ed.
3. Dubey J.P. Toxoplasmosis-a waterborne zoonosis. Vet Parasitol 2004, 126:57-72.
4. Montoya J.G., Liesenfeld O. Toxoplasmosis. Lancet 2004, 363:1965-1976.
5. Dawson D. Foodborne protozoan parasites. Int J Food Microbiol 2005, 103:207-227.
6. Walker M., Zunt J.R. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis 2005, 40:1005-1015.
7. Balasundaram M.B., Andavar R., Palaniswamy M., Venkatapathy N. Outbreak of acquired ocular toxoplasmosis involving 248 patients. Arch Ophthalmol 2010, 128:28-32.
8. Delgado-García G. Toxoplasmosis and mental diseases. Rev Cubana Med Trop 1979, 31:127-131.
9. Alvarado-Esquivel C., Alanis-Quiñones O.P., Arreola-Valenzuela M.A., Rodríguez-Briones A., Piedra-Nevarez L.J., Duran-Morales E., et al. Seroepidemiology of Toxoplasma gondii infection in psychiatric inpatients in a northern Mexican city. BMC Infect Dis 2006, 6:178.
10. Thomas H.V., Thomas D.R., Salmon R.L., Lewis G., Smith A.P. Toxoplasma and Coxiella infection and psychiatric morbidity: a retrospective cohort analysis. BMC Psychiatry 2004, 4:32.
11. Xiao Y., Yin J., Jiang N., Xiang M., Hao L., Lu H., et al. Seroepidemiology of human Toxoplasma gondii infection in China. BMC Infect Dis 2010, 10:4.
12. Torrey E.F., Yolken R.H. Toxoplasma gondii and schizophrenia. Emerg Infect Dis 2003, 9:1375-1380.
13. Torrey E.F., Bartko J.J., Lun Z.R., Yolken R.H. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull 2007, 33:729-736.
14. Clasificación Estadística Internacional de Enfermedades y Problemas relacionados con la Salud 1995, Organización Panamericana de la Salud, Washington, USA. 10th ed.
15. Alvarado-Esquivel C., Liesenfeld O., Torres-Castorena A., Estrada-Martínez S., Urbina-Alvarez J.D., Ramos-de la Rocha M., et al. Seroepidemiology of Toxoplasma gondii infection in patients with vision and hearing impairments, cancer, HIV, or undergoing hemodialysis in Durango, Mexico. J Parasitol 2010, 96:505-508.
16. Alvarado-Esquivel C., Cruz-Magallanes H.M., Esquivel-Cruz R., Estrada-Martínez S., Rivas-González M., Liesenfeld O., et al. Seroepidemiology of Toxoplasma gondii infection in human adults from three rural communities in Durango State, Mexico. J Parasitol 2008, 94:811-816.
17. Alvarado-Esquivel C., Torres-Castorena A., Liesenfeld O., García-López C.R., Estrada-Martínez S., Sifuentes-Alvarez A., et al. Seroepidemiology of Toxoplasma gondii infection in pregnant women in rural Durango, Mexico. J Parasitol 2009, 95:271-274.
18. Alvarado-Esquivel C., Liesenfeld O., Márquez-Conde J.A., Cisneros-Camacho A., Estrada-Martínez S., Martínez-García S.A., et al. Seroepidemiology of infection with Toxoplasma gondii in waste pickers and waste workers in Durango, Mexico. Zoonoses Public Health 2008, 55:306-312.
19. Alvarado-Esquivel C., Mercado-Suárez M.F., Rodríguez-Briones A., Fallad-Torres L., Ayala-Ayala J.O., Nevarez-Piedra L.J., et al. Seroepidemiology of infection with Toxoplasma gondii in healthy blood donors of Durango, Mexico. BMC Infect Dis 2007, 7:75.
20. Buentello E. Comunicación preliminar sobre las relaciones entre toxoplasmosis, ácido lisérgico y esquizofrenia. Gac Méd Méx 1958, 88:693-708.
21. Roch E., Varela G. Diversos aspectos de la investigación sobre toxoplasmosis en México. Resultados obtenidos en 29 883 reacciones de Sabin y Feldman efectuadas de 1953 a 1965. Rev Investig Salud Pública 1966, 26:31-49.
22. El-Sahn A.A., Shatat H.Z., Ghitany E.M. Seropositivity of toxoplasmosis in patients with schizophrenia. J Egypt Public Health Assoc 2005, 80:509-524.
23. Wang H.L., Wang G.H., Li Q.Y., Shu C., Jiang M.S., Guo Y. Prevalence of Toxoplasma infection in first-episode schizophrenia and comparison between Toxoplasma-seropositive and Toxoplasma-seronegative schizophrenia. Acta Psychiatr Scand 2006, 114:40-48.
24. Cetinkaya Z., Yazar S., Gecici O., Namli M.N. Anti-Toxoplasma gondii antibodies in patients with schizophrenia-preliminary findings in a Turkish sample. Schizophr Bull 2007, 33:789-791.
25. Tamer G.S., Dundar D., Yalug I., Caliskan S., Yazar S., Aker A. The schizophrenia and Toxoplasma gondii connection: infectious, immune or both?. Adv Ther 2008, 25:703-709.
26. Yolken R.H., Bachmann S., Ruslanova I., Lillehoj E., Ford G., Torrey E.F., et al. Antibodies to Toxoplasma gondii in individuals with first-episode schizophrenia. Clin Infect Dis 2001, 32:842-844.
27. Mortensen P.B., Nørgaard-Pedersen B., Waltoft B.L., Sørensen T.L., Hougaard D., Torrey E.F., et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry 2007, 61:688-693.
28. Hinze-Selch D., Däubener W., Eggert L., Erdag S., Stoltenberg R., Wilms S.A. A controlled prospective study of Toxoplasma gondii infection in individuals with schizophrenia: beyond seroprevalence. Schizophr Bull 2007, 33:782-788.
29. Niebuhr D.W., Millikan A.M., Cowan D.N., Yolken R., Li Y., Weber N.S. Selected infectious agents and risk of schizophrenia among U.S. military personnel. Am J Psychiatry 2008, 165:99-106.
30. Tsoi W.F. First admission schizophrenia: clinical manifestation and subtypes. Singapore Med J 1993, 34:399-402.
31. Yuksel P., Alpay N., Babur C., Bayar R., Saribas S., Karakose A.R., et al. The role of latent toxoplasmosis in the aetiopathogenesis of schizophrenia-the risk factor or an indication of a contact with cat?. Folia Parasitol 2010, 57:121-128.
32. Krause D., Matz J., Weidinger E., Wagner J., Wildenauer A., Obermeier M., et al. The association of infectious agents and schizophrenia. World J Biol Psychiatry 2010, 11:739-743.